Speaking and Hosting a Workshop at 11th Bioproduction Congress

PharmaKnowl Consulting’s Principal Consultant & CEO will be speaking and hosting a workshop at the 11th Bioproduction Congress 2026, taking place on 22 September 2026 at the Groupama Stadium, Lyon, France.

Session: International Panel | 22 September, 10:00 AM “Understanding the Saudi Biopharma Ecosystem: Opportunities and Realities”, this panel session will bring an on-the-ground perspective on Saudi Arabia’s fast-evolving biopharma landscape, covering the opportunities the market presents for international biotech and biomanufacturing companies, as well as the practical realities of operating within it.

Workshop: Accelerated Regulatory Pathways to Saudi Arabia | 22 September, 11:10 AM “New SFDA Programs by Development Stage”, this workshop will take a closer look at the Saudi Food and Drug Authority’s (SFDA) newer accelerated regulatory pathways, structured by development stage, and what they mean for companies planning a market entry or registration strategy for Saudi Arabia.

As an SFDA-licensed regulatory consulting firm based in Saudi Arabia, PharmaKnowl Consulting supports pharmaceutical and biotechnology companies including biomanufacturers and cell and gene therapy developers in navigating SFDA registration, accelerated approval pathways, and regulatory strategy across the product lifecycle. Our team works closely with international organizations to help translate global development programs into efficient, compliant regulatory pathways in Saudi Arabia and the wider GCC.

If you’re attending the 11th Bioproduction Congress, we invite you to join Mohammad’s session and workshop on 22 September or reach out directly to discuss how PharmaKnowl can support your organization’s regulatory strategy for Saudi Arabia.